# Vitamin B12 deficiency in metformin-treated community-dwelling older adults with diabetes: A cross-sectional multicentre study in Perak

**Authors:** Kin Wei Chua, Abdul Rani Rosilawati, Xing Yi Tang, Ahmad Tajuddin Ainul Hana, Sivaraja Yogeswary, Sariban Suriyati, Razali Norwani, Zainal Abidin Sofiah, Chin Aun Liew, Wee Kooi Cheah

PMC · DOI: 10.51866/oa.718 · Malaysian Family Physician : the Official Journal of the Academy of Family Physicians of Malaysia · 2025-12-22

## TL;DR

This study found that nearly 30% of older adults with diabetes taking metformin in Malaysia have vitamin B12 deficiency, which is linked to aging but not other factors like ethnicity or diabetes duration.

## Contribution

The study provides the first local data on vitamin B12 deficiency prevalence in metformin-treated older diabetic adults in Malaysia.

## Key findings

- 29.4% of participants had vitamin B12 deficiency, with a median level of 287.0 pmol/L.
- Vitamin B12 deficiency was significantly associated with advancing age but not with sex, ethnicity, or diabetes duration.
- The study highlights the need for vitamin B12 screening in older diabetic patients taking metformin in Malaysia.

## Abstract

Surveillance studies have shown a high prevalence of vitamin B12 deficiency in metformin-treated adults. Community-dwelling older adults have a higher risk of vitamin B12 deficiency due to lower gut absorption. To date, data on this specific cohort are lacking. We aimed to investigate the local prevalence of vitamin B12 deficiency and its associated factors among metformin-treated older adults.

This prospective cross-sectional study investigated community-dwelling patients with diabetes aged ≥65 years from four healthcare facilities from August 2023 to March 2024. Blood samples were sent to a central laboratory to determine vitamin B12 levels. Vitamin B12 deficiency was defined as serum vitamin B12 levels of ≤221 pmol/L. Descriptive analysis, chi-square test (or Fisher’s exact test) and independent t-test (or Mann-Whitney U test) were performed.

One hundred two participants were included in the study, of whom 61.8% were women (n=63), and 55.9% were Malays (n=57). The median age was 70 years (interquartile range [IQR]=67-74), and the median duration of metformin usage was 9.0 years (IQR=5.0-12.3). The prevalence of vitamin B12 deficiency was 29.4% (95% confidence interval [CI]=20.4-38.4, n=30), with a median vitamin B12 level of 287.0 pmol/L (IQR=200.5-448.8). Vitamin B12 deficiency was significantly associated with advancing age (P<0.05), but not with sex, ethnicity, duration of diabetes, metformin use, BMI, latest HbA1c level recorded and haemoglobin level (P>0.05).

Patients with diabetes aged ≥65 years have a high prevalence of vitamin B12 deficiency. Blood screening for vitamin B12 deficiency is needed for this population in Peninsular Malaysia.

## Linked entities

- **Chemicals:** metformin (PubChem CID 4091), vitamin B12 (PubChem CID 73415824)
- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), Vitamin B12 deficiency (MESH:D014806)
- **Chemicals:** vitamin B12 (MESH:D014805), metformin (MESH:D008687)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12789806/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12789806/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12789806/full.md

---
Source: https://tomesphere.com/paper/PMC12789806